Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Non-excluding The Pharmaceutical Rabat Agreement According To § 130a Section 8 Sgb V By Means Of An Open-house Model On The Active Substance Omalizumab (atc Code According To Who: R03dx05) 2026-02-21
Germany Medicines With The Active Substance Eltrombopag (atc: B02bx05) 2026-02-21
Germany Eltrombopag (fast Oral Drf: Except The Indication Of Severe Aplastic Anemia)_tk, Hek, Hkk 2026-02-21
Germany Eltrombopag (hard Oral Drf: Including The Indication Of Severe Aplastic Anemia)_tk, Hek, Hkk 2026-02-21
Germany Completion Not Excl. Pharmaceutical Discount Club. According To Section 130a (8) Sgb V By An Open House Model To The Active Ingredient Brinzolamide/brimonidin (official Atc Code: S01ec24) 2026-02-21
Germany The Tender Involves The Conclusion Of Non-exclusive Discount Agreements For Pharmaceuticals Under An Open-house Model For The Active Ingredient Certolizumab Pegol. Certolizumab Pegol 2026-02-21
Germany Medicines With The Active Ingredient Eltrombopag (atc 2026-02-22
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V By An Open House Model To The Active Ingredient Omalizumab (atccode According To Who 2026-02-22
Germany Completion Not Excl. Pharmaceutical Discount Club. According To § 130a Para. 8 Sgb V By Way Of An Open House Model To The Active Ingredient Brinzolamide/brimonidin (official Atcode 2026-02-22
Germany Medicines With The Active Ingredient Rivaroxaban (atc: B01af01 - In All Power Strengths Except 2.5 Mg Each Divided Oral Dosage Form) 2026-02-22
Whats app